Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00404950 · ClinicalTrials.gov registry record

Effects of Hyperglycemia During Cardiopulmonary Bypass on Renal Function

A clinical trial, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
200
Enrollment target

NCT00404950: Completed study, sponsored by Weill Medical College of Cornell University.

NCT00404950 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00404950 has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
200 participants
Enrollment target

Study Summary

To determine whether intraoperative hyperglycemia potentiates renal injury in the setting of cardiac surgery requiring cardiopulmonary bypass.

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2005-07
Est. Completion 2012-07

What the finished NCT00404950 record still lists

NCT00404950 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00404950 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00404950 about?

NCT00404950 is a clinical study titled "Effects of Hyperglycemia During Cardiopulmonary Bypass on Renal Function". To determine whether intraoperative hyperglycemia potentiates renal injury in the setting of cardiac surgery requiring cardiopulmonary bypass.

What is the current status of trial NCT00404950?

This trial is currently completed. The enrollment target is 200 participants. The study started on 2005-07. Estimated completion is 2012-07.

Who is sponsoring clinical trial NCT00404950?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00404950, the US trial registry maintained by the National Library of Medicine. NCT00404950 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.